China’s New Formulary Coming; Little MNC Reactions In Large Hospitals
This article was originally published in PharmAsia News
Executive Summary
China’s new Essential Drug List will likely be implemented not only in grassroots medical institutes, but also in large hospitals with minimal sales and usage ratios.